<!--HTML document created with Certent Disclosure Management 6.6.0.153-->
<!--Created on: 5/19/2017 1:07:32 PM-->
<html>
	<head>
		<title>
			8K 2017-05-17_REVISED
		</title>
	</head>
	<body><div style="margin-left:18pt;margin-right:18pt;">
		<p style="margin:0pt 18pt;line-height:100%;font-family:Calibri;font-size: 10pt">
			<a name="eolPage1"></a><a name="FIS_TOP_OF_DOCUMENT"></a><a name="PACB_20161102X8K_HTM"></a><a name="FIS_FORM"></a><a name="PACB_20161102X8K_HTM__GOBACK"></a><a name="_GoBack"></a><font style="display: inline;font-family:Tahoma;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 18pt;line-height:100%;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Tahoma;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 18pt;line-height:100%;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0.5pt 18pt 0pt 18.5pt;border-bottom:1pt solid #000000 ;line-height:100%;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:3pt 18pt 0pt 21pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 18pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:18pt;">UNITED STATES</font>
		</p>
		<p style="margin:0pt 18pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 18pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:18pt;">SECURITIES AND EXCHANGE COMMISSION</font>
		</p>
		<p style="margin:0pt 18pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:12pt;">Washington, DC 20549</font>
		</p>
		<p style="margin:0pt 18pt;line-height:100%;font-family:Calibri;font-size: 5pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 245.4pt;border-bottom:1pt solid #000000 ;line-height:100%;text-align:center;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:4.5pt 18pt 0pt 22.5pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 18pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:18pt;">FORM 8-K</font>
		</p>
		<p style="margin:0pt 18pt;line-height:100%;font-family:Calibri;font-size: 5pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 245.4pt;border-bottom:1pt solid #000000 ;line-height:100%;text-align:center;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:4.5pt 18pt 0pt 22.5pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 13pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:13.5pt;">CURRENT REPORT</font>
		</p>
		<p style="margin:9pt 18pt 0pt 27pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:12pt;">Pursuant to Section&nbsp;13 or 15(d) of</font>
		</p>
		<p style="margin:0pt 18pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:12pt;">The Securities Exchange Act of 1934</font>
		</p>
		<p style="margin:9pt 18pt 0pt 27pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:12pt;">Date of Report (Date of earliest event reported)</font>
		</p>
		<p style="margin:0pt 18pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:12pt;">May </font><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:12pt;">1</font><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:12pt;">6</font><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:12pt;">, 201</font><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:12pt;">7</font>
		</p>
		<p style="margin:0pt 18pt;line-height:100%;font-family:Calibri;font-size: 5pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 245.4pt;border-bottom:1pt solid #000000 ;line-height:100%;text-align:center;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:4.5pt 18pt 0pt 22.5pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 24pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:24pt;">Pulse Biosciences</font><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:24pt;">, Inc.</font>
		</p>
		<p style="margin:0pt 18pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">(Exact name of registrant as specified in its charter)</font>
		</p>
		<p style="margin:0pt 18pt;line-height:100%;font-family:Calibri;font-size: 5pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 245.4pt;border-bottom:1pt solid #000000 ;line-height:100%;text-align:center;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:2.5pt 18pt 0pt 20.5pt;line-height:100%;font-family:Calibri;font-size: 5pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;margin-left:0pt;">
			<tr>
				<td valign="middle" style="width:181.90pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;height:1.00pt;overflow:hidden;font-size: 1pt">
						<font style="display: inline;font-size:1pt;">&#xFEFF;</font></p>
				</td>
				<td valign="bottom" style="width:07.80pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="middle" style="width:171.25pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.80pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="middle" style="width:171.25pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:181.90pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 5pt">
						<font style="display: inline;font-family:Tahoma;font-size:5pt;">&#xFEFF;</font></p>
				</td>
				<td valign="bottom" style="width:07.80pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="middle" style="width:171.25pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:07.80pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="middle" style="width:171.25pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:181.90pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;font-family:Tahoma;font-size:12pt;">&#xFEFF;</font></p>
				</td>
				<td valign="bottom" style="width:07.80pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="middle" style="width:171.25pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:07.80pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="middle" style="width:171.25pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:181.90pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 1.6pt 0pt 0pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&#xFEFF;</font><a name="FIS_UNIDENTIFIED_TABLE"></a><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">Nevada</font></p>
				</td>
				<td valign="bottom" style="width:07.80pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 1.6pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 7pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:171.25pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 1.6pt 0pt 0pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">001-37744</font></p>
				</td>
				<td valign="bottom" style="width:07.80pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 1.6pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 7pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:171.25pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 1.6pt 0pt 0pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">46-5696597</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:181.90pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 1.6pt 0pt 0pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 7pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:7.5pt;">(State or other jurisdiction</font></p>
					<p style="margin:0pt 1.6pt 0pt 0pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 7pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:7.5pt;">of incorporation)</font></p>
				</td>
				<td valign="bottom" style="width:07.80pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 1.6pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 7pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:171.25pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 1.6pt 0pt 0pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 7pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:7.5pt;">(Commission</font></p>
					<p style="margin:0pt 1.6pt 0pt 0pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 7pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:7.5pt;">File Number)</font></p>
				</td>
				<td valign="bottom" style="width:07.80pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 1.6pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 7pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:171.25pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 1.6pt 0pt 0pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 7pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:7.5pt;">(IRS Employer</font></p>
					<p style="margin:0pt 1.6pt 0pt 0pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 7pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:7.5pt;">Identification No.)</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:9pt 18pt 0pt 27pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">849 Mitten Road</font>
		</p>
		<p style="margin:0pt 18pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">Burlingame</font><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">, California 940</font><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">10</font>
		</p>
		<p style="margin:0pt 18pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 7pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:7.5pt;">(Address of principal executive offices, including zip code)</font>
		</p>
		<p style="margin:9pt 18pt 0pt 27pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">(650) </font><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">697</font><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">-</font><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">3939</font>
		</p>
		<p style="margin:0pt 18pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 7pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:7.5pt;">(Registrant&#x2019;s telephone number, including area code)</font>
		</p>
		<p style="margin:18pt 18pt 0pt 36pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 7pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:7.5pt;">(Former name or former address, if changed since last report)</font>
		</p>
		<p style="margin:0pt 18pt;line-height:100%;font-family:Calibri;font-size: 5pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 245.4pt;border-bottom:1pt solid #000000 ;line-height:100%;text-align:center;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:4.5pt 18pt 0pt 22.5pt;line-height:100%;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-size:10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2):</font>
		</p>
		<p style="margin:4.5pt 18pt 0pt 22.5pt;line-height:100%;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Tahoma;font-size:10pt;">&#xFEFF;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;">
			<tr>
				<td valign="middle" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;height:1.00pt;overflow:hidden;font-size: 1pt">
						<font style="display: inline;font-size:1pt;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="width:03.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="middle" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:89.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;font-family:Calibri;line-height:107.92%;font-size: 12pt">
						<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="width:03.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 4.5pt;line-height:100%;font-family:Calibri;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">&#x2610;</font></p>
				</td>
				<td valign="middle" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;font-family:Calibri;line-height:107.92%;font-size: 11pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:89.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 4.5pt;line-height:100%;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-size:10pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;font-family:Calibri;line-height:107.92%;font-size: 12pt">
						<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="width:03.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 4.5pt;line-height:100%;font-family:Calibri;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">&#x2610;</font></p>
				</td>
				<td valign="middle" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;font-family:Calibri;line-height:107.92%;font-size: 11pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:89.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 4.5pt;line-height:100%;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-size:10pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;font-family:Calibri;line-height:107.92%;font-size: 12pt">
						<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="width:03.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 4.5pt;line-height:100%;font-family:Calibri;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">&#x2610;</font></p>
				</td>
				<td valign="middle" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;font-family:Calibri;line-height:107.92%;font-size: 11pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:89.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 4.5pt;line-height:100%;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-size:10pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;font-family:Calibri;line-height:107.92%;font-size: 12pt">
						<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="width:03.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 4.5pt;line-height:100%;font-family:Calibri;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">&#x2610;</font></p>
				</td>
				<td valign="middle" style="width:03.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;font-family:Calibri;line-height:107.92%;font-size: 11pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:89.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 4.5pt;line-height:100%;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-size:10pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt 18pt;line-height:100%;font-family:Calibri;font-size: 5pt">
			<font style="display: inline;font-family:Times New Roman;font-size:5pt;">&nbsp; &nbsp;</font>
		</p>
		<p style="margin:0pt 16.75pt 10.35pt 0pt;border-bottom:1pt none #D9D9D9 ;line-height:100%;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-family:Tahoma;">&#xFEFF;</font><font style="display: inline;color:#000000;font-size:10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#xA7;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#xA7;240.12b-2 of this chapter). </font>
		</p>
		<p style="margin:0pt 0pt 5.25pt 382.5pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;line-height:100%;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;color:#000000;font-size:10pt;">Emerging growth company </font><font style="display: inline;font-family:Segoe UI Symbol;color:#000000;font-size:8pt;">&#x2612;</font>
		</p>
		<p style="margin:0pt;border-top:1pt none #D9D9D9 ;line-height:100%;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;color:#000000;font-size:10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><font style="display: inline;font-family:Segoe UI Symbol;color:#000000;font-size:8pt;">&#x2612;</font><font style="display: inline;font-size:10pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt 18pt;line-height:100%;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 18pt;line-height:100%;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 18pt;line-height:100%;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0.5pt 18pt 0pt 18.5pt;border-bottom:1pt solid #000000 ;line-height:100%;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:11.25pt 18pt 0pt;font-family:Calibri;line-height:107.92%;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p>
		<p style="margin:0pt;line-height:100%;font-family:Calibri;;font-size: 12pt"><font style="display: inline;font-family:Tahoma;font-size:12pt;">&#xFEFF;</font><a name="FIS_SECTION_2_FINANCIAL_INFORMATION"></a><a name="FIS_RESULTS_OF_OPERATIONS"></a>
		</p>
		<p style="margin:12pt 0pt 0pt;line-height:100%;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:11pt;"><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">Item 5.02.</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;"></font><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</font></font>
		</p>
		<p style="margin:12pt 0pt 0pt;line-height:100%;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:5pt;"><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">(e) </font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;"></font></font>
		</p>
		<p style="margin:12pt 0pt 0pt;line-height:100%;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">2017 Equity Incentive Plan</font>
		</p>
		<p style="margin:12pt 0pt 0pt;line-height:100%;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-size:10pt;">The Board of Directors (the &#x201C;Board&#x201D;) of Pulse Biosciences, Inc. (the &#x201C;Company&#x201D;) previously adopted, subject to stockholder approval, the Company&#x2019;s 2017 Equity Incentive Plan (the &#x201C;2017 Plan&#x201D;). The Company&#x2019;s stockholders approved the 2017 Plan at the annual meeting of stockholders held on May 16, 2017 (the &#x201C;Annual Meeting&#x201D;).</font>
		</p>
		<p style="margin:12pt 0pt 0pt;line-height:100%;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-size:10pt;">The 2017 Plan has a 10-year term, and provides for the grant of stock options, stock appreciation rights, restricted stock, restricted stock units, performance units, and performance shares to employees, directors and consultants of the Company and any parent or subsidiary of the Company, as the plan administrator may determine.</font><font style="display: inline;font-family:Calibri;font-size:10pt;">&nbsp;</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">Subject to an </font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">annual evergreen increase and adjustment in the case of certain capitalization events, 1,500,000 shares of our common stock are authorized for issuance pursuant to awards under the 2017 Plan. In addition, shares remaining available under our 2015 Equity Incentive Plan, as amended (the &#x201C;2015 Plan&#x201D;), and shares reserved but not issued pursuant to outstanding equity awards that expire or terminate without being exercised or that are forfeited or repurchased by the Company will be added to the shares of common stock available for issuance under the 2017 Plan. The 2017 Plan will be administered by our Compensation Committee.</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;border-bottom:1pt none #D9D9D9 ;line-height:100%;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;border-top:1pt none #D9D9D9 ;line-height:100%;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-size:10pt;">On May 16, 2017, the Board granted Brian Dow, the Company&#x2019;s Senior Vice President and Chief Financial Officer, an option to purchase 95,000 shares of the Company&#x2019;s common stock at an exercise price of $27.14 per share.&nbsp;&nbsp;The option will vest in equal </font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">monthly installments over a four-year period commencing February 15, 2017, subject to his continued serviced through each vesting date.&nbsp;&nbsp;The options were granted pursuant to the terms and conditions of the 2017 Plan and the form of option agreement thereunder.</font>
		</p>
		<p style="margin:12pt 0pt 0pt;line-height:100%;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-size:10pt;">The terms and conditions of the 2017 Plan are described in the Company&#x2019;s Proxy Statement dated April 18, 2017. The description of the 2017 Plan contained herein is qualified in its entirety by reference to the full text of the 2017 Plan, a copy of which is filed as Exhibit 10.1 hereto and is incorporated herein by reference.&nbsp; </font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">Grants under the 2017 Plan will be made pursuant to the forms of agreement thereunder, forms of which are filed with Exhibit&nbsp;10.1 hereto and incorporated herein by reference.</font>
		</p>
		<p style="margin:12pt 0pt 0pt;line-height:100%;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">2017 Employee Stock Purchase Plan</font></font>
		</p>
		<p style="margin:12pt 0pt 0pt;line-height:100%;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-size:10pt;">The Board of the Company previously adopted, subject to stockholder approval, the Company&#x2019;s 2017 Employee Stock Purchase Plan (the &#x201C;2017 ESPP&#x201D;). At the Company&#x2019;s Annual Meeting on May 16, 2017, the Company&#x2019;s shareholders approved the 2017 ESPP. </font>
		</p>
		<p style="margin:12pt 0pt 0pt;line-height:100%;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-size:10pt;">The 2017 ESPP is as broad-based plan that provides employees of the Company and its designated affiliates with the opportunity to become shareholders through periodic payroll deductions that are applied towards the purchase of Company common shares at a discount from the then-current market price. Subject to adjustment in the case of certain capitalization events, a total of 250,000 common shares of the Company are available for purchase under the 2017 ESPP. </font>
		</p>
		<p style="margin:12pt 0pt 0pt;line-height:100%;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-size:10pt;">The terms and conditions of the 2017 ESPP are described in the Company&#x2019;s Proxy Statement dated April 18, 2017. The description of the 2017 ESPP is qualified in its entirety by reference to the full text of the 2017 ESPP, a copy of which is filed as Exhibit 10.2 hereto and is incorporated herein by reference. </font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">Participation under the 2017 Plan will be made pursuant to the forms of agreement thereunder, forms of which are filed with Exhibit&nbsp;10.2 hereto and incorporated herein by reference.</font>
		</p>
		<p style="margin:0pt 0pt 8pt;font-family:Calibri;line-height:107.92%;font-size: 10pt">

		</p>
		<p><font size="1"> </font></p><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p>
		<p style="margin:0pt 0pt 8pt;font-family:Calibri;line-height:107.92%;;font-size: 10pt"><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;"></font>
		</p>
		<p style="margin:12pt 0pt 0pt;line-height:100%;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:11pt;"><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">Item 5.07.</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">Submission of Matters to a Vote of Security Holders.</font></font>
		</p>
		<p style="margin:12pt 0pt 0pt;line-height:100%;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-size:10pt;">On May 16, 2017, the Company held its Annual Meeting at 3957 Point Eden Way, Hayward, California 94545. The stockholders of the Company voted on the following items at the Annual Meeting:</font>
		</p>
		<p style="margin:0pt 18pt;line-height:100%;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-size:10pt;">&#xFEFF;</font>
		</p>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:54pt;"><p style="width:54pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;">
			<p style="line-height:100%;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt;margin:0pt 18pt 0pt 0pt;">
				<font style="margin:0pt 18pt 0pt 0pt;line-height:100%;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size:10pt;;"> 1.</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="line-height:100%;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt;margin:0pt 18pt 0pt 0pt;">
			<font style="display: inline;font-family:Times New Roman;font-size:10pt;color:#000000;">To elect six directors to hold office until the Company&#x2019;s 2018 annual meeting and until their successors are duly elected and qualified, subject to earlier resignation or removal; </font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:54pt;"><p style="width:54pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;">
			<p style="line-height:100%;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt;margin:0pt 18pt 0pt 0pt;">
				<font style="margin:0pt 18pt 0pt 0pt;line-height:100%;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size:10pt;;"> 2.</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="line-height:100%;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt;margin:0pt 18pt 0pt 0pt;">
			<font style="display: inline;font-family:Times New Roman;font-size:10pt;color:#000000;">To approve the adoption of the Company&#x2019;s 2017 Equity Incentive Plan; </font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:54pt;"><p style="width:54pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;">
			<p style="line-height:100%;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt;margin:0pt 18pt 0pt 0pt;">
				<font style="margin:0pt 18pt 0pt 0pt;line-height:100%;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size:10pt;;"> 3.</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="line-height:100%;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt;margin:0pt 18pt 0pt 0pt;">
			<font style="display: inline;font-family:Times New Roman;font-size:10pt;color:#000000;">To approve the adoption of the Company&#x2019;s 2017 Employee Stock Purchase Plan; and</font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:54pt;"><p style="width:54pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;">
			<p style="line-height:100%;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt;margin:0pt 18pt 0pt 0pt;">
				<font style="margin:0pt 18pt 0pt 0pt;line-height:100%;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size:10pt;;"> 4.</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="line-height:100%;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt;margin:0pt 18pt 0pt 0pt;">
			<font style="display: inline;font-family:Times New Roman;font-size:10pt;color:#000000;">To ratify the appointment of Gumbiner Savett Inc. as the Company&#x2019;s independent registered public accounting firm for the fiscal year ending December 31, 2017.</font></p></td></tr></table></div>
		<p style="margin:12pt 0pt 0pt;line-height:100%;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-size:10pt;color:#000000;">The voting results for each of these proposals are detailed below:</font>
		</p>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;"><p style="width:36pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 100%;text-indent:18pt; display: inline;">
			<p style="line-height:100%;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt;margin:12pt 0pt 0pt;">
				<font style="margin:12pt 0pt 0pt;font-weight:bold;font-style:italic;line-height:100%;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size:10pt;;;padding:0pt 10pt 0pt 0pt;"> 1.</font>
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;color:#000000;">Election of Directors </font></p></td></tr></table></div>
		<p style="margin:0pt 18pt 0pt 36pt;line-height:100%;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-size:10pt;color:#000000;">&#xFEFF;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;">
			<tr>
				<td valign="bottom" style="width:28.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:3.50pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;height:3.50pt;font-size: 10pt">
						<font style="display: inline;font-size:10pt;color:#000000;">&#xFEFF;</font></p>
				</td>
				<td valign="bottom" style="width:17.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:3.50pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;height:3.50pt;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:17.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:3.50pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;height:3.50pt;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:18.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:3.50pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;height:3.50pt;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:17.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:3.50pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;height:3.50pt;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:28.12%;height:14.40pt;padding:0pt 6.5pt">
					<p style="margin:0pt;border-bottom:1pt solid #000000 ;line-height:107.08%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;color:#000000;font-size:10pt;">Nominee</font></p>
				</td>
				<td valign="bottom" style="width:17.96%;height:14.40pt;padding:0pt 6.5pt">
					<p style="margin:0pt;border-bottom:1pt solid #000000 ;line-height:107.08%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;color:#000000;font-size:10pt;">For</font></p>
				</td>
				<td valign="bottom" style="width:17.96%;height:14.40pt;padding:0pt 6.5pt">
					<p style="margin:0pt;border-bottom:1pt solid #000000 ;line-height:107.08%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;color:#000000;font-size:10pt;">Against</font></p>
				</td>
				<td valign="bottom" style="width:18.00%;height:14.40pt;padding:0pt 6.5pt">
					<p style="margin:0pt;border-bottom:1pt solid #000000 ;line-height:107.08%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;color:#000000;font-size:10pt;">A</font><font style="display: inline;font-family:Times New Roman;font-weight:bold;color:#000000;font-size:10pt;">bstained</font></p>
				</td>
				<td valign="bottom" style="width:17.94%;height:14.40pt;padding:0pt 6.5pt">
					<p style="margin:0pt;border-bottom:1pt solid #000000 ;line-height:107.08%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;color:#000000;font-size:10pt;">Broker Non-votes</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:28.12%;background-color: #CCEEFF;height:12.25pt;padding:0pt 6.5pt">
					<p style="margin:0pt;line-height:106.67%;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-size:10pt;color:#000000;">Darrin R. Uecker </font></p>
				</td>
				<td valign="bottom" style="width:17.96%;background-color: #CCEEFF;height:12.25pt;padding:0pt 6.5pt">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;color:#000000;font-size:10pt;">7,925,350</font></p>
				</td>
				<td valign="bottom" style="width:17.96%;background-color: #CCEEFF;height:12.25pt;padding:0pt 6.5pt">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;color:#000000;font-size:10pt;">94</font></p>
				</td>
				<td valign="bottom" style="width:18.00%;background-color: #CCEEFF;height:12.25pt;padding:0pt 6.5pt">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;color:#000000;font-size:10pt;">1,490</font></p>
				</td>
				<td valign="bottom" style="width:17.94%;background-color: #CCEEFF;height:12.25pt;padding:0pt 6.5pt">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;color:#000000;font-size:10pt;">3,927,209</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:28.12%;height:12.25pt;padding:0pt 6.5pt">
					<p style="margin:0pt;line-height:106.67%;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-size:10pt;color:#000000;">Robert M. Levande</font></p>
				</td>
				<td valign="bottom" style="width:17.96%;height:12.25pt;padding:0pt 6.5pt">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;color:#000000;font-size:10pt;">7,920,791</font></p>
				</td>
				<td valign="bottom" style="width:17.96%;height:12.25pt;padding:0pt 6.5pt">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;color:#000000;font-size:10pt;">4,683</font></p>
				</td>
				<td valign="bottom" style="width:18.00%;height:12.25pt;padding:0pt 6.5pt">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;color:#000000;font-size:10pt;">1,460</font></p>
				</td>
				<td valign="bottom" style="width:17.94%;height:12.25pt;padding:0pt 6.5pt">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;color:#000000;font-size:10pt;">3,927,209</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:28.12%;background-color: #CCEEFF;height:12.25pt;padding:0pt 6.5pt">
					<p style="margin:0pt;line-height:106.67%;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;color:#000000;font-size:10pt;">Robert J. Greenberg, M.D., Ph.D.</font></p>
				</td>
				<td valign="bottom" style="width:17.96%;background-color: #CCEEFF;height:12.25pt;padding:0pt 6.5pt">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;color:#000000;font-size:10pt;">7,883,311</font></p>
				</td>
				<td valign="bottom" style="width:17.96%;background-color: #CCEEFF;height:12.25pt;padding:0pt 6.5pt">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;color:#000000;font-size:10pt;">42,183</font></p>
				</td>
				<td valign="bottom" style="width:18.00%;background-color: #CCEEFF;height:12.25pt;padding:0pt 6.5pt">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;color:#000000;font-size:10pt;">1,440</font></p>
				</td>
				<td valign="bottom" style="width:17.94%;background-color: #CCEEFF;height:12.25pt;padding:0pt 6.5pt">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;color:#000000;font-size:10pt;">3,927,209</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:28.12%;height:12.25pt;padding:0pt 6.5pt">
					<p style="margin:0pt;line-height:106.67%;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;color:#000000;font-size:10pt;">Mitchell E. Levinson</font></p>
				</td>
				<td valign="bottom" style="width:17.96%;height:12.25pt;padding:0pt 6.5pt">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;color:#000000;font-size:10pt;">6,718,336</font></p>
				</td>
				<td valign="bottom" style="width:17.96%;height:12.25pt;padding:0pt 6.5pt">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;color:#000000;font-size:10pt;">42,105</font></p>
				</td>
				<td valign="bottom" style="width:18.00%;height:12.25pt;padding:0pt 6.5pt">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;color:#000000;font-size:10pt;">1,166,493</font></p>
				</td>
				<td valign="bottom" style="width:17.94%;height:12.25pt;padding:0pt 6.5pt">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;color:#000000;font-size:10pt;">3,927,209</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:28.12%;background-color: #CCEEFF;height:12.25pt;padding:0pt 6.5pt">
					<p style="margin:0pt;line-height:106.67%;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;color:#000000;font-size:10pt;">Thierry Thaure </font></p>
				</td>
				<td valign="bottom" style="width:17.96%;background-color: #CCEEFF;height:12.25pt;padding:0pt 6.5pt">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;color:#000000;font-size:10pt;">6,718,475</font></p>
				</td>
				<td valign="bottom" style="width:17.96%;background-color: #CCEEFF;height:12.25pt;padding:0pt 6.5pt">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;color:#000000;font-size:10pt;">42,113</font></p>
				</td>
				<td valign="bottom" style="width:18.00%;background-color: #CCEEFF;height:12.25pt;padding:0pt 6.5pt">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;color:#000000;font-size:10pt;">1,166,346</font></p>
				</td>
				<td valign="bottom" style="width:17.94%;background-color: #CCEEFF;height:12.25pt;padding:0pt 6.5pt">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;color:#000000;font-size:10pt;">3,927,209</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:28.12%;height:12.25pt;padding:0pt 6.5pt">
					<p style="margin:0pt;line-height:106.67%;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-size:10pt;color:#000000;">Maky Zanganeh, D.D.S</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;color:#000000;">.</font></p>
				</td>
				<td valign="bottom" style="width:17.96%;height:12.25pt;padding:0pt 6.5pt">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;color:#000000;font-size:10pt;">6,760,112</font></p>
				</td>
				<td valign="bottom" style="width:17.96%;height:12.25pt;padding:0pt 6.5pt">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;color:#000000;font-size:10pt;">533</font></p>
				</td>
				<td valign="bottom" style="width:18.00%;height:12.25pt;padding:0pt 6.5pt">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;color:#000000;font-size:10pt;">1,166,289</font></p>
				</td>
				<td valign="bottom" style="width:17.94%;height:12.25pt;padding:0pt 6.5pt">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;color:#000000;font-size:10pt;">3,927,209</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:12pt 0pt 0pt;line-height:100%;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-size:10pt;color:#000000;">Each director nominee was duly elected to serve until the 2018 annual meeting of stockholders and until his or her successor is duly elected and qualified. </font>
		</p>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;"><p style="width:36pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 100%;text-indent:18pt; display: inline;">
			<p style="line-height:100%;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt;margin:12pt 0pt 0pt;">
				<font style="margin:12pt 0pt 0pt;font-weight:bold;font-style:italic;line-height:100%;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size:10pt;;;padding:0pt 10pt 0pt 0pt;"> 2.</font>
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;color:#000000;">Adoption of the 2017 Equity Incentive Plan</font></p></td></tr></table></div>
		<p style="margin:0pt 18pt 0pt 36pt;line-height:100%;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;color:#000000;">&#xFEFF;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;">
			<tr>
				<td valign="top" style="width:25.00%;padding:0pt 6.9pt 0pt 6.9pt;">
					<p style="margin:0pt;border-bottom:1pt solid #000000 ;line-height:107.08%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;color:#000000;">For</font></p>
				</td>
				<td valign="top" style="width:25.00%;padding:0pt 6.9pt 0pt 6.9pt;">
					<p style="margin:0pt;border-bottom:1pt solid #000000 ;line-height:107.08%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;color:#000000;">Against</font></p>
				</td>
				<td valign="top" style="width:25.00%;padding:0pt 6.9pt 0pt 6.9pt;">
					<p style="margin:0pt;border-bottom:1pt solid #000000 ;line-height:107.08%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;color:#000000;">Abstained</font></p>
				</td>
				<td valign="top" style="width:25.00%;padding:0pt 6.9pt 0pt 6.9pt;">
					<p style="margin:0pt;border-bottom:1pt solid #000000 ;line-height:107.08%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;color:#000000;">Broker Non-votes</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:25.00%;background-color: #CCEEFF;padding:0pt 6.9pt 0pt 6.9pt;height:14.40pt">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;color:#000000;font-size:10pt;">6,497,539</font></p>
				</td>
				<td valign="top" style="width:25.00%;background-color: #CCEEFF;padding:0pt 6.9pt 0pt 6.9pt;height:14.40pt">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;color:#000000;font-size:10pt;">258,216</font></p>
				</td>
				<td valign="top" style="width:25.00%;background-color: #CCEEFF;padding:0pt 6.9pt 0pt 6.9pt;height:14.40pt">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;color:#000000;font-size:10pt;">1,171,179</font></p>
				</td>
				<td valign="top" style="width:25.00%;background-color: #CCEEFF;padding:0pt 6.9pt 0pt 6.9pt;height:14.40pt">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;color:#000000;font-size:10pt;">3,927,209</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:12pt 0pt 0pt;line-height:100%;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-size:10pt;color:#000000;">The stockholders approved the adoption of the Company&#x2019;s 2017 Equity Incentive Plan, as described in the proxy materials. </font>
		</p>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;"><p style="width:36pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 100%;text-indent:18pt; display: inline;">
			<p style="line-height:100%;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt;margin:12pt 0pt 0pt;">
				<font style="margin:12pt 0pt 0pt;font-weight:bold;font-style:italic;line-height:100%;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size:10pt;;;padding:0pt 10pt 0pt 0pt;"> 3.</font>
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;color:#000000;">Adoption of the 2017 Employee Stock Purchase Plan</font></p></td></tr></table></div>
		<p style="margin:0pt;line-height:106.67%;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Calibri;font-size:10pt;color:#000000;">&#xFEFF;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;">
			<tr>
				<td valign="top" style="width:25.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.9pt 0pt 6.9pt;height:1.00pt">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;height:1.00pt;overflow:hidden;font-size: 10pt">
						<font style="display: inline;font-size:10pt;color:#000000;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="width:25.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.9pt 0pt 6.9pt;height:1.00pt">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:25.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.9pt 0pt 6.9pt;height:1.00pt">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:25.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.9pt 0pt 6.9pt;height:1.00pt">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:25.00%;padding:0pt 6.9pt 0pt 6.9pt;">
					<p style="margin:0pt;border-bottom:1pt solid #000000 ;line-height:107.08%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;color:#000000;">&#xFEFF;</font><a name="_Hlk482788377"></a><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;color:#000000;">For</font></p>
				</td>
				<td valign="top" style="width:25.00%;padding:0pt 6.9pt 0pt 6.9pt;">
					<p style="margin:0pt;border-bottom:1pt solid #000000 ;line-height:107.08%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;color:#000000;">Against</font></p>
				</td>
				<td valign="top" style="width:25.00%;padding:0pt 6.9pt 0pt 6.9pt;">
					<p style="margin:0pt;border-bottom:1pt solid #000000 ;line-height:107.08%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;color:#000000;">Abstained</font></p>
				</td>
				<td valign="top" style="width:25.00%;padding:0pt 6.9pt 0pt 6.9pt;">
					<p style="margin:0pt;border-bottom:1pt solid #000000 ;line-height:107.08%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;color:#000000;">Broker Non-votes</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:25.00%;background-color: #CCEEFF;padding:0pt 6.9pt 0pt 6.9pt;height:12.25pt">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;color:#000000;font-size:10pt;">6,548,156</font></p>
				</td>
				<td valign="top" style="width:25.00%;background-color: #CCEEFF;padding:0pt 6.9pt 0pt 6.9pt;height:12.25pt">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;color:#000000;font-size:10pt;">209,244</font></p>
				</td>
				<td valign="top" style="width:25.00%;background-color: #CCEEFF;padding:0pt 6.9pt 0pt 6.9pt;height:12.25pt">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;color:#000000;font-size:10pt;">1,169,534</font></p>
				</td>
				<td valign="top" style="width:25.00%;background-color: #CCEEFF;padding:0pt 6.9pt 0pt 6.9pt;height:12.25pt">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;color:#000000;font-size:10pt;">3,927,209</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:12pt 0pt 0pt;line-height:100%;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-size:10pt;color:#000000;">The stockholders approved the adoption of the Company&#x2019;s 2017 Employee Stock Purchase Plan, as described in the proxy materials. </font>
		</p>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;"><p style="width:36pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 100%;text-indent:18pt; display: inline;">
			<p style="line-height:100%;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt;margin:12pt 0pt 0pt;">
				<font style="margin:12pt 0pt 0pt;font-weight:bold;font-style:italic;line-height:100%;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size:10pt;;;padding:0pt 10pt 0pt 0pt;"> 4.</font>
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;color:#000000;">Ratification of Appointment of Independent Registered Public Accounting Firm </font></p></td></tr></table></div>
		<p style="margin:0pt 18pt 0pt 0pt;line-height:100%;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;color:#000000;">&#xFEFF;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;">
			<tr>
				<td valign="top" style="width:25.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.9pt 0pt 6.9pt;height:1.00pt">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;height:1.00pt;overflow:hidden;font-size: 10pt">
						<font style="display: inline;font-size:10pt;color:#000000;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="width:25.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.9pt 0pt 6.9pt;height:1.00pt">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:25.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.9pt 0pt 6.9pt;height:1.00pt">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:25.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.9pt 0pt 6.9pt;height:1.00pt">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:25.00%;padding:0pt 6.9pt 0pt 6.9pt;height:14.40pt">
					<p style="margin:0pt;border-bottom:1pt solid #000000 ;line-height:107.08%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;color:#000000;">For</font></p>
				</td>
				<td valign="top" style="width:25.00%;padding:0pt 6.9pt 0pt 6.9pt;height:14.40pt">
					<p style="margin:0pt;border-bottom:1pt solid #000000 ;line-height:107.08%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;color:#000000;">Against</font></p>
				</td>
				<td valign="top" style="width:25.00%;padding:0pt 6.9pt 0pt 6.9pt;height:14.40pt">
					<p style="margin:0pt;border-bottom:1pt solid #000000 ;line-height:107.08%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;color:#000000;">Abstained</font></p>
				</td>
				<td valign="top" style="width:25.00%;padding:0pt 6.9pt 0pt 6.9pt;height:14.40pt">
					<p style="margin:0pt;border-bottom:1pt solid #000000 ;line-height:107.08%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;color:#000000;">Broker Non-votes</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:25.00%;background-color: #CCEEFF;padding:0pt 6.9pt 0pt 6.9pt;height:12.25pt">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;color:#000000;font-size:10pt;">10,613,633</font></p>
				</td>
				<td valign="top" style="width:25.00%;background-color: #CCEEFF;padding:0pt 6.9pt 0pt 6.9pt;height:12.25pt">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;color:#000000;font-size:10pt;">63,336</font></p>
				</td>
				<td valign="top" style="width:25.00%;background-color: #CCEEFF;padding:0pt 6.9pt 0pt 6.9pt;height:12.25pt">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;color:#000000;font-size:10pt;">1,177,174</font></p>
				</td>
				<td valign="top" style="width:25.00%;background-color: #CCEEFF;padding:0pt 6.9pt 0pt 6.9pt;height:12.25pt">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;color:#000000;font-size:10pt;">N/A</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:12pt 0pt 0pt;line-height:100%;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-size:10pt;color:#000000;">The stockholders ratified the appointment of </font><font style="display: inline;font-family:Times New Roman;font-size:10pt;color:#000000;">Gumbiner Savett Inc. as the Company&#x2019;s independent registered public accounting firm for the fiscal year ending December 31, 2017. </font>
		</p>
		<p style="margin:12pt 0pt 0pt;line-height:100%;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;color:#000000;">Item 8.01. Other Events </font>
		</p>
		<p style="margin:12pt 0pt 0pt;line-height:100%;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-size:10pt;color:#000000;">&nbsp;</font><font style="display: inline;font-family:Times New Roman;font-style:italic;font-size:10pt;color:#000000;">Termination of Rights Offering Obligation Pursuant to Underwriting Agreement</font>
		</p>
		<p style="margin:12pt 0pt 0pt;line-height:100%;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-size:10pt;color:#000000;">Pursuant to the Underwriting Agreement, included as Exhibit 1.1 to the Form S-1/A filed with the Securities and Exchange Commission on May 3, 2016 and entered into in connection with the Company&#x2019;s initial public offering, the Company, subject to certain exceptions, shall not sell or issue any shares of its capital stock, (or securities convertible or exercisable into its capital stock) unless the Company first offers, in respect of such sale or issuance, to the then record holders (including &#x201C;street name&#x201D; holders) of its common stock, the right to subscribe to capital stock on a pro-rata basis (the &#x201C;Rights Offering Obligation&#x201D;). Pursuant to the terms of the Underwriting Agreement, the Rights Offering Obligation terminates upon the 91</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;color:#000000;font-size:5pt;vertical-align:super;line-height:100%">st</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;color:#000000;"> consecutive calendar day period in which the closing price for the Company&#x2019;s common stock as reported by The Nasdaq Capital Market has been at least $12.00 per share (the &#x201C;Rights Offering Expiration Date&#x201D;).&nbsp;&nbsp;The Rights Offering Expiration Date occurred on May 17, 2017, and the Rights Offering Obligation terminated on such date in accordance with the terms of the Underwriting Agreement.</font>
		</p>
		<p style="margin:9pt 18pt 0pt 27pt;line-height:100%;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-size:10pt;color:#000000;">&#xFEFF;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;margin-left:18pt;">
			<tr>
				<td valign="middle" style="width:49.50pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;height:1.00pt;overflow:hidden;font-size: 10pt">
						<font style="display: inline;font-size:10pt;color:#000000;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="width:13.50pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:476.95pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr></table>
		<p><font size="1"> </font></p><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p>
		<table cellpadding="0" cellspacing="0" style="border-collapse:collapse;margin-left:18pt;">
			<tr>
				<td valign="top" style="width:49.50pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 6.55pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Tahoma;font-weight:bold;font-size:10pt;color:#000000;">&#xFEFF;</font></p>
					<p style="margin:0pt 6.55pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;color:#000000;">Item&nbsp;9.01.</font></p>
				</td>
				<td colspan="2" valign="top" style="width:490.45pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 1.6pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;">&nbsp;</font></p>
					<p style="margin:0pt 1.6pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;color:#000000;">Financial Statements and Exhibits</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:49.50pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3.75pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Tahoma;font-size:10pt;color:#000000;">&#xFEFF;</font></p>
				</td>
				<td colspan="2" valign="top" style="width:490.45pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 2.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:49.50pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-size:10pt;text-decoration:underline;color:#000000;">Exhibit No.</font></p>
				</td>
				<td valign="bottom" style="width:13.50pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 1.75pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:476.95pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-size:10pt;text-decoration:underline;color:#000000;">Description</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:49.50pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-size:10pt;color:#000000;">10.1</font></p>
				</td>
				<td valign="bottom" style="width:13.50pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 1.75pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:476.95pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;color:#000000;">&nbsp;2017 Equity Incentive Plan and forms of agreement thereunder.</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:49.50pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Tahoma;font-size:10pt;color:#000000;">&#xFEFF;</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;color:#000000;">10.2</font></p>
				</td>
				<td valign="bottom" style="width:13.50pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 1.75pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:476.95pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-size:10pt;color:#000000;">&nbsp;2017 Employee Stock Purchase Plan and forms of agreement thereunder.</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt 18pt;line-height:100%;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Tahoma;font-size:10pt;color:#000000;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 18pt;font-family:Calibri;line-height:107.92%;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-size:10pt;color:#000000;">&#xFEFF;</font>
		</p>
		<p style="margin:11.25pt 18pt 0pt;font-family:Calibri;line-height:107.92%;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-size:10pt;color:#000000;">&#xFEFF;</font>
		</p>
		<p style="margin:11.25pt 18pt 0pt;line-height:100%;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-size:10pt;color:#000000;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p>
		<p style="margin:0pt;line-height:100%;font-family:Calibri;;font-size: 12pt"><font style="display: inline;font-family:Tahoma;font-size:12pt;color:#000000;">&#xFEFF;</font>
		</p>
		<p style="margin:12.25pt 19pt 0pt 19.75pt;border-top:1pt solid #808080 ;border-left:1pt solid #808080 ;border-bottom:1pt solid #808080 ;border-right:1pt solid #808080 ;line-height:100%;text-align:center;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Tahoma;font-size:12pt;color:#000000;">&#xFEFF;</font><a name="FIS_SIGNATURES"></a>
		</p>
		<p style="margin:11.25pt 18pt 0pt 29.25pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;color:#000000;">SIGNATURE</font>
		</p>
		<p style="margin:9pt 18pt 0pt 27pt;line-height:100%;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-size:10pt;color:#000000;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font>
		</p>
		<p style="margin:0pt 18pt;line-height:100%;font-family:Calibri;font-size: 9pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" align="right" style="border-collapse:collapse;margin-left:0pt;">
			<tr>
				<td valign="middle" style="width:18.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;height:1.00pt;overflow:hidden;font-size: 1pt">
						<font style="display: inline;font-size:1pt;color:#000000;">&#xFEFF;</font></p>
				</td>
				<td valign="bottom" style="width:01.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="middle" style="width:192.50pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:18.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;font-family:Times New Roman;font-size:12pt;color:#000000;">&#xFEFF;</font></p>
				</td>
				<td valign="bottom" style="width:01.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="middle" style="width:192.50pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:18.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;font-family:Tahoma;font-size:12pt;color:#000000;">&#xFEFF;</font></p>
				</td>
				<td valign="bottom" style="width:01.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="middle" style="width:192.50pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td colspan="3" valign="top" style="width:211.50pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 5.6pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;color:#000000;">Pulse Biosciences, Inc.</font></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:18.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;font-family:Tahoma;font-size:12pt;color:#000000;">&#xFEFF;</font></p>
				</td>
				<td colspan="2" valign="middle" style="width:193.50pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 1.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:18.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 1.6pt 0pt 10pt;line-height:100%;text-indent: -10pt;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-size:10pt;color:#000000;">By:</font></p>
				</td>
				<td valign="bottom" style="width:01.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 1.6pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 7pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:192.50pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 1.6pt 0pt 0pt;border-bottom:1pt solid #000000 ;line-height:100%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-size:10pt;color:#000000;">/s/ Brian B. Dow &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:18.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;font-family:Tahoma;font-size:12pt;color:#000000;">&#xFEFF;</font></p>
				</td>
				<td valign="bottom" style="width:01.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 1.6pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 7pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:192.50pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 1.6pt 0pt 0pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;color:#000000;">Brian B. Dow</font></p>
					<p style="margin:0pt 1.6pt 0pt 0pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-style:italic;font-size:10pt;color:#000000;">Senior Vice President and Chief Financial Officer</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt 18pt;line-height:100%;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Tahoma;font-size:12pt;color:#000000;">&#xFEFF;</font>
		</p>
		<p style="margin:9pt 18pt 0pt 27pt;line-height:100%;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-size:10pt;color:#000000;">Date: </font><font style="display: inline;font-family:Times New Roman;font-size:10pt;color:#000000;">May </font><font style="display: inline;font-family:Times New Roman;font-size:10pt;color:#000000;">1</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;color:#000000;">9</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;color:#000000;">, 201</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;color:#000000;">7</font>
		</p>
		<p style="margin:9pt 18pt 0pt 27pt;line-height:100%;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:9pt 18pt 0pt 27pt;text-align:center;font-family:Calibri;line-height:107.92%;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;color:#000000;">&#xFEFF;</font>
		</p>
		<p style="margin:11.25pt 18pt 0pt;font-family:Calibri;line-height:107.92%;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;color:#000000;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 18pt;line-height:100%;font-family:Calibri;font-size: 11pt">
			<font style="display: inline;font-family:Tahoma;color:#000000;">&#xFEFF;</font>
		</p>
		<p style="margin:11.25pt 18pt 0pt;font-family:Calibri;line-height:107.92%;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;color:#000000;">&#xFEFF;</font>
		</p>
		<p><font size="1"> </font></p><hr size="3" style="color:#999999" width="100%" align="center"></hr>
	</div></body>
</html>
[{"type": "8-K", "sequence": "1", "filename": "plse-20170519x8k.htm", "description": "8-K", "secsgml_size_bytes": 97063}]
{"company-data": {"conformed-name": "Pulse Biosciences, Inc.", "cik": "0001625101", "assigned-sic": "3841", "irs-number": "465696597", "state-of-incorporation": "NV", "fiscal-year-end": "1217"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-37744", "film-number": "17858177"}, "business-address": {"street1": "849 MITTEN ROAD", "street2": "SUITE 104", "city": "BURLINGAME", "state": "CA", "zip": "94010", "phone": "650-697-3939"}, "mail-address": {"street1": "849 MITTEN ROAD", "street2": "SUITE 104", "city": "BURLINGAME", "state": "CA", "zip": "94010"}, "former-company": {"former-conformed-name": "Electroblate, Inc.", "date-changed": "20141113"}}
8K 2017-05-17_REVISED
﻿
﻿
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
May
1
6
, 201
7
Pulse Biosciences
, Inc.
(Exact name of registrant as specified in its charter)
﻿
﻿
﻿
﻿
Nevada
001-37744
46-5696597
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
849 Mitten Road
Burlingame
, California 940
10
(Address of principal executive offices, including zip code)
(650)
697
-
3939
(Registrant's telephone number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2):
﻿
﻿
﻿
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
﻿
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
﻿
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
﻿
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
﻿
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☒
﻿
﻿
﻿
Item 5.02.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(e)
2017 Equity Incentive Plan
The Board of Directors (the "Board") of Pulse Biosciences, Inc. (the "Company") previously adopted, subject to stockholder approval, the Company's 2017 Equity Incentive Plan (the "2017 Plan"). The Company's stockholders approved the 2017 Plan at the annual meeting of stockholders held on May 16, 2017 (the "Annual Meeting").
The 2017 Plan has a 10-year term, and provides for the grant of stock options, stock appreciation rights, restricted stock, restricted stock units, performance units, and performance shares to employees, directors and consultants of the Company and any parent or subsidiary of the Company, as the plan administrator may determine.
Subject to an
annual evergreen increase and adjustment in the case of certain capitalization events, 1,500,000 shares of our common stock are authorized for issuance pursuant to awards under the 2017 Plan. In addition, shares remaining available under our 2015 Equity Incentive Plan, as amended (the "2015 Plan"), and shares reserved but not issued pursuant to outstanding equity awards that expire or terminate without being exercised or that are forfeited or repurchased by the Company will be added to the shares of common stock available for issuance under the 2017 Plan. The 2017 Plan will be administered by our Compensation Committee.
﻿
On May 16, 2017, the Board granted Brian Dow, the Company's Senior Vice President and Chief Financial Officer, an option to purchase 95,000 shares of the Company's common stock at an exercise price of $27.14 per share.  The option will vest in equal
monthly installments over a four-year period commencing February 15, 2017, subject to his continued serviced through each vesting date.  The options were granted pursuant to the terms and conditions of the 2017 Plan and the form of option agreement thereunder.
The terms and conditions of the 2017 Plan are described in the Company's Proxy Statement dated April 18, 2017. The description of the 2017 Plan contained herein is qualified in its entirety by reference to the full text of the 2017 Plan, a copy of which is filed as Exhibit 10.1 hereto and is incorporated herein by reference.
Grants under the 2017 Plan will be made pursuant to the forms of agreement thereunder, forms of which are filed with Exhibit 10.1 hereto and incorporated herein by reference.
2017 Employee Stock Purchase Plan
The Board of the Company previously adopted, subject to stockholder approval, the Company's 2017 Employee Stock Purchase Plan (the "2017 ESPP"). At the Company's Annual Meeting on May 16, 2017, the Company's shareholders approved the 2017 ESPP.
The 2017 ESPP is as broad-based plan that provides employees of the Company and its designated affiliates with the opportunity to become shareholders through periodic payroll deductions that are applied towards the purchase of Company common shares at a discount from the then-current market price. Subject to adjustment in the case of certain capitalization events, a total of 250,000 common shares of the Company are available for purchase under the 2017 ESPP.
The terms and conditions of the 2017 ESPP are described in the Company's Proxy Statement dated April 18, 2017. The description of the 2017 ESPP is qualified in its entirety by reference to the full text of the 2017 ESPP, a copy of which is filed as Exhibit 10.2 hereto and is incorporated herein by reference.
Participation under the 2017 Plan will be made pursuant to the forms of agreement thereunder, forms of which are filed with Exhibit 10.2 hereto and incorporated herein by reference.
Item 5.07.
Submission of Matters to a Vote of Security Holders.
On May 16, 2017, the Company held its Annual Meeting at 3957 Point Eden Way, Hayward, California 94545. The stockholders of the Company voted on the following items at the Annual Meeting:
﻿
1.
To elect six directors to hold office until the Company's 2018 annual meeting and until their successors are duly elected and qualified, subject to earlier resignation or removal;
2.
To approve the adoption of the Company's 2017 Equity Incentive Plan;
3.
To approve the adoption of the Company's 2017 Employee Stock Purchase Plan; and
4.
To ratify the appointment of Gumbiner Savett Inc. as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2017.
The voting results for each of these proposals are detailed below:
1.
Election of Directors
﻿
﻿
Nominee
For
Against
A
bstained
Broker Non-votes
Darrin R. Uecker
7,925,350
94
1,490
3,927,209
Robert M. Levande
7,920,791
4,683
1,460
3,927,209
Robert J. Greenberg, M.D., Ph.D.
7,883,311
42,183
1,440
3,927,209
Mitchell E. Levinson
6,718,336
42,105
1,166,493
3,927,209
Thierry Thaure
6,718,475
42,113
1,166,346
3,927,209
Maky Zanganeh, D.D.S
.
6,760,112
533
1,166,289
3,927,209
Each director nominee was duly elected to serve until the 2018 annual meeting of stockholders and until his or her successor is duly elected and qualified.
2.
Adoption of the 2017 Equity Incentive Plan
﻿
For
Against
Abstained
Broker Non-votes
6,497,539
258,216
1,171,179
3,927,209
The stockholders approved the adoption of the Company's 2017 Equity Incentive Plan, as described in the proxy materials.
3.
Adoption of the 2017 Employee Stock Purchase Plan
﻿
﻿
﻿
For
Against
Abstained
Broker Non-votes
6,548,156
209,244
1,169,534
3,927,209
The stockholders approved the adoption of the Company's 2017 Employee Stock Purchase Plan, as described in the proxy materials.
4.
Ratification of Appointment of Independent Registered Public Accounting Firm
﻿
﻿
For
Against
Abstained
Broker Non-votes
10,613,633
63,336
1,177,174
N/A
The stockholders ratified the appointment of
Gumbiner Savett Inc. as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2017.
Item 8.01. Other Events
Termination of Rights Offering Obligation Pursuant to Underwriting Agreement
Pursuant to the Underwriting Agreement, included as Exhibit 1.1 to the Form S-1/A filed with the Securities and Exchange Commission on May 3, 2016 and entered into in connection with the Company's initial public offering, the Company, subject to certain exceptions, shall not sell or issue any shares of its capital stock, (or securities convertible or exercisable into its capital stock) unless the Company first offers, in respect of such sale or issuance, to the then record holders (including "street name" holders) of its common stock, the right to subscribe to capital stock on a pro-rata basis (the "Rights Offering Obligation"). Pursuant to the terms of the Underwriting Agreement, the Rights Offering Obligation terminates upon the 91
st
consecutive calendar day period in which the closing price for the Company's common stock as reported by The Nasdaq Capital Market has been at least $12.00 per share (the "Rights Offering Expiration Date").  The Rights Offering Expiration Date occurred on May 17, 2017, and the Rights Offering Obligation terminated on such date in accordance with the terms of the Underwriting Agreement.
﻿
﻿
﻿
Item 9.01.
Financial Statements and Exhibits
﻿
Exhibit No.
Description
10.1
2017 Equity Incentive Plan and forms of agreement thereunder.
﻿
10.2
2017 Employee Stock Purchase Plan and forms of agreement thereunder.
﻿
﻿
﻿
﻿
﻿
﻿
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
﻿
﻿
﻿
Pulse Biosciences, Inc.
﻿
By:
/s/ Brian B. Dow
﻿
Brian B. Dow
Senior Vice President and Chief Financial Officer
﻿
Date:
May
1
9
, 201
7
﻿
﻿
﻿
﻿